STERIS’ (TSE:STE – Free Report) – Investment analysts at Cormark cut their FY2025 earnings per share (EPS) estimates for shares of STERIS’ in a research note issued on Tuesday, November 5th. Cormark analyst B. Watson now forecasts that the company will earn $0.94 per share for the year, down from their prior forecast of $1.02.
STERIS’ Stock Performance
STERIS’ (TSE:STE – Get Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The company reported C$0.14 earnings per share for the quarter, beating the consensus estimate of C$0.12 by C$0.02. The company had revenue of C$231.38 million for the quarter, compared to the consensus estimate of C$226.20 million.
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
See Also
- Five stocks we like better than STERIS’
- How to Use the MarketBeat Dividend Calculator
- AMD: The AI Disruptor – Is It Time to Follow Big Tech’s Lead?
- Comparing and Trading High PE Ratio Stocks
- Analysts Signal Big Upside: Top 3 Stocks to Watch Right Now
- Why Are These Companies Considered Blue Chips?
- Bears Misjudged These 3 ETFs: Where Investors Can Find Upside
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
